维普期刊资源整合服务平台（V6.5）

40篇 您的检索式：作者名="ENGELMAN B"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Caveolin-2 deficient mice show evidence of severe pulmonary dysfunction without disruption of caveolae显示文摘	Razani B Wang XB Engelman JA Battista M Lagaud G Zhang XL	2002	Mol Cell Biol2002，22，：	1
2	Activity and safety of crizotinib in patients with ALK -positive non-small-cell lung cancer: updated results from a phase 1 study显示文摘	D Ross Camidge Yung-Jue Bang Eunice L Kwak A John Iafrate Marileila Varella-Garcia Stephen B Fox Gregory J Riely Benjamin Solomon Sai-Hong I Ou Dong-Wan Kim Ravi Salgia Panagiotis Fidias Jeffrey A Engelman Leena Gandhi Pasi A J?nne Daniel B Costa Geoffrey	2012	Lancet Oncology2012，，10：	1
3	Caveolin- 1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities显示文摘	Razani B Engelman JA Wang XB	2001	J Biol Chem2001，276，38：	1
4	Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis显示文摘	Alice T Shaw Beow Y Yeap Benjamin J Solomon Gregory J Riely Justin Gainor Jeffrey A Engelman Geoffrey I Shapiro Daniel B Costa Sai-Hong I Ou Mohit Butaney Ravi Salgia Robert G Maki Marileila Varella-Garcia Robert C Doebele Yung-Jue Bang Kimary Kulig Pauli	2011	Lancet Oncology2011，，11：	1
5	Activity and safety of crizotinib in patients with ALK -positive non-small-cell lung cancer: updated results from a phase 1 study显示文摘	D Ross Camidge Yung-Jue Bang Eunice L Kwak A John Iafrate Marileila Varella-Garcia Stephen B Fox Gregory J Riely Benjamin Solomon Sai-Hong I Ou Dong-Wan Kim Ravi Salgia Panagiotis Fidias Jeffrey A Engelman Leena Gandhi Pasi A J?nne Daniel B Costa Geoffrey	2012	Lancet Oncology2012，，10：	1
6	Best Prac- tice in Understanding and Managing Lost Circulation Chal- lenges 显示文摘	Wang Hong (Max) Sweatman R Engelman B	2005	SPE958952005，，：	1
7	Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities显示文摘	Razani B Engelman J A Wang X B	2001	J Biol Chem2001，276，38：	1
8	Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis显示文摘	Alice T Shaw Beow Y Yeap Benjamin J Solomon Gregory J Riely Justin Gainor Jeffrey A Engelman Geoffrey I Shapiro Daniel B Costa Sai-Hong I Ou Mohit Butaney Ravi Salgia Robert G Maki Marileila Varella-Garcia Robert C Doebele Yung-Jue Bang Kimary Kulig Pauli	2011	Lancet Oncology2011，，11：	1
9	Activity and safety of crizotinib in patients with ALK -positive non-small-cell lung cancer: updated results from a phase 1 study显示文摘	D Ross Camidge Yung-Jue Bang Eunice L Kwak A John Iafrate Marileila Varella-Garcia Stephen B Fox Gregory J Riely Benjamin Solomon Sai-Hong I Ou Dong-Wan Kim Ravi Salgia Panagiotis Fidias Jeffrey A Engelman Leena Gandhi Pasi A J?nne Daniel B Costa Geoffrey	2012	Lancet Oncology2012，，10：	1
10	Control of excitatory and inhibitory synapse formation by neuroligins 显示文摘	Chih B Engelman H Scheiffele P	2005	Science2005，307，5713：	1
11	The PI3K pathway as drug target in human cancer显示文摘	Courtney K D Corcoran R B Engelman J A	2010	J Clin Oncol2010，28，6：	1
12	Control of excitatory and inhibitory synapse formation by neuroligins显示文摘	Chih B Engelman H Scheiffele P		0，，5713：	1
13	Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis显示文摘	Alice T Shaw Beow Y Yeap Benjamin J Solomon Gregory J Riely Justin Gainor Jeffrey A Engelman Geoffrey I Shapiro Daniel B Costa Sai-Hong I Ou Mohit Butaney Ravi Salgia Robert G Maki Marileila Varella-Garcia Robert C Doebele Yung-Jue Bang Kimary Kulig Pauli	2011	Lancet Oncology2011，，11：	1
14	Caveolin-2-deficient mice show evidence of severe pulmonary dysfunction without dis- ruption of caveolae显示文摘	Razani B Wang XB Engelman JA	2002	Mol CeU Biol2002，22，7：	1
15	Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities显示文摘	Razani B Engelman JA Wang XB	2001	J Biol Chem2001，276，38：	1
16	Control of excitatory and inhibitory synapse formation by neuroligins显示文摘	Chi B Engelman H Scheiffele P	2005	Sci- ence2005，307，5713：	1
17	Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities显示文摘	Razani B Engelman JA Wang XB Schubert W Zhang XL Marks CB	2001	J Biol Chem2001，276，38：	1
18	The PI3K pathway as drug target in human cancer 显示文摘	Courtney K D Corcoran R B Engelman J A	2010	J Clin Oncol2010，28，6：	1
19	Caveolin-1null mice are viable,but show evidence of hyperproliferative and vascular abnormalities显示文摘	Razani B Engelman JA Wang XB	2009	J Biol Chem2009，276，38：	1
20	Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities显示文摘	Razani B Engelman J A Wang X B	2001	J Biol Chem2001，276，38：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示